Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report.

HER-2 positive atypical microglandular adenosis breast carcinoma lobular carcinoma in situ matrix-producing carcinoma metaplastic carcinoma microglandular adenosis pleomorphic lobular carcinoma in situ triple negative

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
13 Jun 2022
Historique:
received: 15 03 2022
revised: 18 05 2022
accepted: 10 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Microglandular adenosis is a non-lobulocentric haphazard proliferation of small round glands composed of a single layer of flat to cuboidal epithelial cells. The glandular structures lack a myoepithelial layer; however, they are surrounded by a basement membrane. Its clinical course is benign, when it is not associated with invasive carcinoma. In around 30% of cases, there is a gradual transition to atypical microglandular adenosis, carcinoma in situ, and invasive breast carcinoma of several different histologic subtypes, including an invasive carcinoma of no special type, metaplastic matrix-producing carcinoma, secretory carcinoma, metaplastic carcinoma with squamous differentiation, acinic cell carcinoma, spindle cell carcinoma, and adenoid cystic carcinoma. Recent molecular studies suggest that microglandular adenosis is a non-obligate precursor of triple-negative breast carcinomas. In this manuscript, we present a unique case of microglandular adenosis associated with metaplastic matrix-producing carcinoma and HER-2 neu oncoprotein positive pleomorphic lobular carcinoma in situ with apocrine differentiation in a 79-year-old patient.

Identifiants

pubmed: 35741268
pii: diagnostics12061458
doi: 10.3390/diagnostics12061458
pmc: PMC9221961
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

J Pathol. 2016 Apr;238(5):677-88
pubmed: 26806567
Am J Surg Pathol. 2008 Apr;32(4):544-52
pubmed: 18300793
J Pathol Transl Med. 2017 Jul;51(4):422-427
pubmed: 28372344
Int J Clin Exp Pathol. 2015 Jul 01;8(7):8568-72
pubmed: 26339435
Virchows Arch. 2017 Jul;471(1):3-12
pubmed: 28528509
Cureus. 2019 Sep 1;11(9):e5550
pubmed: 31695973
Arch Pathol Lab Med. 2020 Jan;144(1):42-46
pubmed: 31116044
Surg Pathol Clin. 2018 Mar;11(1):123-145
pubmed: 29413653
Pathol Int. 2010 Oct;60(10):685-9
pubmed: 20846267
Virchows Arch. 2005 Feb;446(2):142-9
pubmed: 15583933
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6149-56
pubmed: 25337263
Int J Surg Pathol. 2019 Oct;27(7):781-787
pubmed: 31046496
J Pathol Clin Res. 2021 May;7(3):220-232
pubmed: 33382535
Cureus. 2019 Jul 22;11(7):e5188
pubmed: 31565596
Mod Pathol. 2021 Jan;34(Suppl 1):38-47
pubmed: 33024304
Cancers (Basel). 2020 Jul 08;12(7):
pubmed: 32650408
Am J Surg Pathol. 1983 Dec;7(8):731-7
pubmed: 6660348
Hum Pathol. 1989 Jul;20(7):628-35
pubmed: 2544506
Mod Pathol. 2020 Jun;33(6):1078-1091
pubmed: 31907376
JAMA. 2005 Mar 2;293(9):1073-81
pubmed: 15741529
Pathol Int. 2011 Jul;61(7):415-22
pubmed: 21707845
Cancer Control. 2001 Sep-Oct;8(5):431-41
pubmed: 11579340
Am J Clin Pathol. 1993 Nov;100(5):507-13
pubmed: 7504394
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
J Clin Oncol. 2006 Jun 20;24(18):2757-64
pubmed: 16782916
Lancet Oncol. 2021 Jul;22(7):e327-e340
pubmed: 34000244
Am J Surg Pathol. 2009 Apr;33(4):496-504
pubmed: 19047897
Hum Pathol. 2018 Dec;82:1-9
pubmed: 29949742
Am J Surg Pathol. 1983 Mar;7(2):137-44
pubmed: 6859388
Pathol Int. 2009 Jun;59(6):390-4
pubmed: 19490469
Crit Rev Oncol Hematol. 2008 May;66(2):171-80
pubmed: 18160303
J Pathol Transl Med. 2017 Jul;51(4):418-421
pubmed: 28372347
Int J Surg Pathol. 2000 Oct;8(4):303-315
pubmed: 11494007
J Clin Oncol. 2019 Sep 10;37(26):2338-2348
pubmed: 31339827
Hum Pathol. 2019 Mar;85:65-71
pubmed: 30428388
Oncologist. 2017 Mar;22(3):335-342
pubmed: 28220025
J Clin Oncol. 2006 Jun 20;24(18):2750-6
pubmed: 16782915
Histopathology. 2012 May;60(6B):E115-30
pubmed: 22486256

Auteurs

Nektarios Koufopoulos (N)

Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece.

Dionysios Dimas (D)

Breast Unit, Athens Medical Center, Psychiko Clinic, 11525 Athens, Greece.

Foteini Antoniadou (F)

Department of Pathology, "Alexandra" General Hospital, 11528 Athens, Greece.

Kyparissia Sitara (K)

Department of Internal Medicine, "Elpis" General Hospital of Athens, 11522 Athens, Greece.

Dimitrios Balalis (D)

Department of Surgical Oncology, Saint Savvas Anticancer Hospital of Athens, 11522 Athens, Greece.

Ioannis Boutas (I)

Breast Unit, Rea Maternity Hospital, P. Faliro, 17564 Athens, Greece.

Alina Roxana Gouloumis (AR)

Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece.

Adamantia Kontogeorgi (A)

Third Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece.

Lubna Khaldi (L)

Department of Pathology, Saint Savvas Anticancer Hospital of Athens, 11522 Athens, Greece.

Classifications MeSH